Purple Biotech (PPBT) Short Interest Ratio & Short Volume → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free PPBT Stock Alerts $0.55 +0.04 (+7.85%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Purple Biotech Short Interest DataCurrent Short Volume233,500 sharesPrevious Short Volume222,200 sharesChange Vs. Previous Month+5.09%Dollar Volume Sold Short$132,324.45Short Interest Ratio / Days to Cover2.0Last Record DateApril 15, 2024Outstanding Shares25,240,000 sharesPercentage of Shares Shorted0.93%Today's Trading Volume62,153 sharesAverage Trading Volume131,474 sharesToday's Volume Vs. Average47% Short Selling Purple Biotech ? Sign up to receive the latest short interest report for Purple Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPPBT Short Interest Over TimePPBT Days to Cover Over TimePPBT Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Purple Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024233,500 shares $132,324.45 +5.1%N/A2 $0.57 3/31/2024222,200 shares $148,874.00 -0.4%N/A2.3 $0.67 3/15/2024223,000 shares $161,641.55 -24.6%N/A2.2 $0.72 2/29/2024295,900 shares $249,857.96 -6.2%N/A2.9 $0.84 2/15/2024315,400 shares $239,672.46 -24.6%N/A3.5 $0.76 1/31/2024418,100 shares $275,946.00 -7.7%N/A5.2 $0.66 Get the Latest News and Ratings for PPBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024452,800 shares $312,432.00 -4.7%N/A4.6 $0.69 12/31/2023475,100 shares $370,578.00 -13.5%N/A4.6 $0.78 12/15/2023548,900 shares $521,455.00 +7.8%N/A5.2 $0.95 11/30/2023509,100 shares $529,464.00 -8.6%N/A5.6 $1.04 11/15/2023556,700 shares $578,968.00 -20.5%N/A6.4 $1.04 10/31/2023700,100 shares $945,135.00 -6.5%N/A8.1 $1.35 10/15/2023748,400 shares $950,468.00 +15.9%N/A9.5 $1.27 9/30/2023645,900 shares $768,621.00 -0.1%N/A7.1 $1.19 9/15/2023646,600 shares $724,192.00 -4.7%N/A7.5 $1.12 8/31/2023678,400 shares $820,864.00 -0.5%N/A7.7 $1.21 8/15/2023681,600 shares $763,392.00 -2.5%N/A8 $1.12 7/31/2023698,700 shares $761,583.00 -11.3%N/A8.5 $1.09 7/15/2023787,900 shares $961,238.00 +17.2%N/A11.2 $1.22 6/30/2023672,100 shares $937,579.50 -0.5%N/A11.5 $1.40 6/15/2023675,400 shares $1.08 million -0.3%N/A21.5 $1.60 5/31/2023677,700 shares $1.19 million -0.3%N/A23.6 $1.76 5/15/2023679,900 shares $1.23 million -2.7%N/A22 $1.81 4/30/2023698,800 shares $1.41 million +1.5%N/A19 $2.02 4/15/2023688,600 shares $1.36 million -0.2%N/A16.8 $1.97 3/31/2023690,100 shares $1.24 million -5.7%N/A16.5 $1.79 3/15/2023731,600 shares $1.51 million -0.4%N/A16 $2.07 2/28/2023734,500 shares $1.47 million -3.0%N/A15.7 $2.00 2/15/2023757,400 shares $1.70 million +3.8%N/A16 $2.25 1/31/2023729,800 shares $1.16 million -3.8%N/A16.1 $1.59 1/15/2023758,400 shares $1.21 million -3.9%N/A18.8 $1.59 12/30/2022789,400 shares $1.09 million -5.2%N/A20 $1.38 12/15/2022832,400 shares $1.27 million -3.5%N/A23.6 $1.53 11/30/2022862,200 shares $1.69 million -0.6%N/A21.1 $1.96 11/15/2022867,500 shares $1.87 million -0.5%N/A11 $2.16 10/31/2022871,500 shares $1.86 million -1.0%N/A11.3 $2.13 10/15/2022880,000 shares $1.74 million -0.7%N/A11 $1.98 9/30/2022886,000 shares $1.80 million -4.1%N/A10.7 $2.03 9/15/2022924,100 shares $1.98 million +10.2%N/A10.6 $2.14 8/31/2022838,400 shares $1.97 million -0.6%N/A9.8 $2.35Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself PPBT Short Interest - Frequently Asked Questions What is Purple Biotech's current short interest? Short interest is the volume of Purple Biotech shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 233,500 shares of PPBT short. Learn More on Purple Biotech's current short interest. What is a good short interest ratio for Purple Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PPBT shares currently have a short interest ratio of 2.0. Learn More on Purple Biotech's short interest ratio. Is Purple Biotech's short interest increasing or decreasing? Purple Biotech saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 233,500 shares, an increase of 5.1% from the previous total of 222,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Purple Biotech's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Purple Biotech: Kiora Pharmaceuticals, Inc. (0.31%), Monopar Therapeutics Inc. (2.01%), Imunon, Inc. (4.96%), RedHill Biopharma Ltd. (2.51%), Avalo Therapeutics, Inc. (14.89%), Pieris Pharmaceuticals, Inc. (0.03%), Elevai Labs, Inc. (0.32%), Akari Therapeutics, Plc (0.01%), Moleculin Biotech, Inc. (1.24%), MIRA Pharmaceuticals, Inc. (0.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Purple Biotech stock? Short selling PPBT is an investing strategy that aims to generate trading profit from Purple Biotech as its price is falling. PPBT shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Purple Biotech? A short squeeze for Purple Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PPBT, which in turn drives the price of the stock up even further. How often is Purple Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPBT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Kiora Pharmaceuticals Short Interest Data Monopar Therapeutics Short Interest Data Imunon Short Interest Data RedHill Biopharma Short Interest Data Avalo Therapeutics Short Interest Data Pieris Pharmaceuticals Short Interest Data Elevai Labs Short Interest Data Akari Therapeutics Short Interest Data Moleculin Biotech Short Interest Data MIRA Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PPBT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsHow Biden has already won 2024Porter & Company